Cathie Wood’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,200
Closed -$72K 232
2022
Q3
$72K Hold
2,200
﹤0.01% 239
2022
Q2
$71K Hold
2,200
﹤0.01% 341
2022
Q1
$101K Buy
+2,200
New +$105K ﹤0.01% 343

Other funds holding ARKG

Cathie Wood's ARKG Position: Q2 2026 in Review

Cathie Wood reduced its ARK Genomic Revolution ETF (ARKG) stake by 76% in Q2 2026, selling an estimated $163K and leaving 1,659 shares worth $69.8K. The position accounts for ﹤0.01% of the portfolio, ranked #179.

Cathie Wood first reported a position in ARKG in Q4 2020 and has held it in 23 quarters since. The position peaked at $3.27M in Q4 2021. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Cathie Wood held 1,659 shares of ARK Genomic Revolution ETF worth $69.8K as of Q2 2026.
  • Cathie Wood sold 5,114 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $163K.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Cathie Wood's portfolio in Q2 2026, its #179 holding.
  • Cathie Wood first reported a position in ARK Genomic Revolution ETF in Q4 2020 and has held it in 23 quarters since.
  • Cathie Wood's ARK Genomic Revolution ETF position peaked at $3.27M in Q4 2021.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on ARK Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.